scholarly journals Idiopathic giant cell myocarditis or cardiac sarcoidosis? A retrospective audit of a nationwide case series

2020 ◽  
Vol 7 (3) ◽  
pp. 1362-1370 ◽  
Author(s):  
Kaj Ekström ◽  
Anne Räisänen‐Sokolowski ◽  
Jukka Lehtonen ◽  
Hanna‐Kaisa Nordenswan ◽  
Mikko I. Mäyränpää ◽  
...  
2017 ◽  
Vol 38 (suppl_1) ◽  
Author(s):  
D. Velikanova ◽  
J. Lehtonen ◽  
P. Simonen ◽  
M. Kupari

2017 ◽  
Vol 38 (suppl_1) ◽  
Author(s):  
H.-K. Nordenswan ◽  
K. Ekstrom ◽  
J. Lehtonen ◽  
M. Kupari ◽  

2018 ◽  
Vol 131 (7-8) ◽  
pp. 186-187
Author(s):  
Petr Kuchynka ◽  
Tomas Palecek ◽  
Lukas Lambert ◽  
Antonin Fikrle ◽  
Ivana Vitkova ◽  
...  

2012 ◽  
Vol 21 ◽  
pp. S81
Author(s):  
M. Brown ◽  
S. McKenzie ◽  
G. Javorsky ◽  
D. Korczyk ◽  
D. Platts

2019 ◽  
Vol 20 (4) ◽  
pp. 264-266 ◽  
Author(s):  
Concetta Di Nora ◽  
Daniela Miani ◽  
Sandro Sponga ◽  
Ugolino Livi

2012 ◽  
Vol 18 (6) ◽  
pp. 733-746 ◽  
Author(s):  
Lori A. Blauwet ◽  
Leslie T. Cooper

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Hari Bogabathina ◽  
Peter Olson ◽  
Vikas K. Rathi ◽  
Robert W. W. Biederman

Giant cell myocarditis, but not cardiac sarcoidosis, is known to cause fulminant myocarditis resulting in severe heart failure. However, giant cell myocarditis and cardiac sarcoidosis are pathologically similar, and attempts at pathological differentiation between the two remain difficult. We are presenting a case of fulminant myocarditis that has pathological features suggestive of cardiac sarcoidosis, but clinically mimicking giant cell myocarditis. This patient was treated with cyclosporine and prednisone and recovered well. This case we believe challenges our current understanding of these intertwined conditions. By obtaining a sense of severity of cardiac involvement via delayed hyperenhancement of cardiac magnetic resonance imaging, we were more inclined to treat this patient as giant cell myocarditis with cyclosporine. This resulted in excellent improvement of patient’s cardiac function as shown by delayed hyperenhancement images, early perfusion images, and SSFP videos.


2021 ◽  
Vol 5 (3) ◽  
Author(s):  
Ginger Y Jiang ◽  
Qizhe Cai ◽  
E Wilson Grandin ◽  
Marwa A Sabe

Abstract Background Severe cardiac sarcoidosis (CS) can share clinical and histopathologic features with giant cell myocarditis (GCM). Case summary A 56-year-old female presented with 1 week of exertional chest pressure and dyspnoea. Echocardiogram demonstrated extensive regional dysfunction with left ventricular ejection fraction (LVEF) 38%. Cardiac catheterization revealed no obstructive coronary artery disease and cardiac index 1.5 L/min/m2. Cardiac magnetic resonance imaging (MRI) demonstrated diffuse late gadolinium enhancement. Positron emission tomography with fluorodeoxyglucose (FDG) (FDG-PET) computed tomography showed FDG uptake in the anteroseptal and anterior wall and no extracardiac activity. Endomyocardial biopsy (EMB) demonstrated fragments of endocardial fibrosis with mixed inflammatory infiltrate including histiocytic giant cells, which could be due to CS or GCM. She was initially treated for GCM with high dose steroids, tacrolimus, and mycophenolate mofetil. Repeat EMB was pursued and demonstrated multiple granulomas with sharp demarcation from adjacent uninvolved myocardium consistent with CS. A dual-chamber implantable cardioverter-defibrillator was placed, and immunosuppression was changed to prednisone alone with plan for infliximab. Discussion This case illustrates a rare presentation of fulminant isolated CS. Endomyocardial biopsy with sufficient tissue was critical to establish a diagnosis and initiate appropriate immunosuppression.


Sign in / Sign up

Export Citation Format

Share Document